We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why Small-Cap HealthCare ETFs & Stocks Are Good Picks
Read MoreHide Full Article
Healthcare stocks are seen as relatively defensive and can provide safety to one’s portfolio during market downturns, which has been the case this year now. Ebbing fears related to price gouging, flurry of positive clinical trials, increasing health care spending, decent valuation have also been benefiting the sector.
Two particular factors are likely to act as wind beneath the wings of the healthcare sector, pushing up small-cap healthcare stocks and the related funds.
Tax Reform
Per an article published on Reuters, domestically geared healthcare companies that focus on services are likely to benefit from the lower tax rate. These companies have limited international exposure and considerable capital expenditures, as per the source.
Mizuho Securities indicated that “tax reform should be a significant positive cash flow event, especially for healthcare services companies that tend to have limited international exposure and significant capital expenditures.”
Merger and Acquisition
The U.S. healthcare supply chain is consolidating fast, with deals across the industry ranging from insurers, pharmacies to drug distributors. According to an article published on Bloomberg, smaller insurers like WellCare Health Plans Inc. , Centene Corp. (CNC - Free Report) , Molina Healthcare Inc. (MOH - Free Report) and Obamacare-focused startup Oscar Insurance Corp. appear to be lucrative acquisition targets. These companies may merge among themselves or can be lapped up by larger insurers eyeing scale advantage in a specific business area (read: Cigna to Buy Express Scripts: Healthcare ETFs in Focus).
The range of M&A activity is spreading beyond the healthcare sector. Leerink Partners analyst Ana Gupte noted retail giant, Walmart Inc. (WMT - Free Report) “has a co-branded Medicare drug plan with Humana that steers patients to Walmart stores -- which could make the retailer a prospective buyer of Humana.”
Like many analysts, we also believe that, if, as an investor, one wants to make a lot from a buyout premium, targeting small-cap stocks would be the best choice.
Against this backdrop, we highlight a few small-cap oriented stocks and ETFs for investors.
ETF Picks
PowerShares S&P SmallCap Health Care Portfolio (PSCH - Free Report)
The fund targets the S&P SmallCap 600 Capped Health Care Index. The 77-stock fund has a keen focus on Healthcare Equipment, Pharmaceuticals Suppliers and Providers & Services, which account for about 75% of the portfolio. The fund charges 29 bps in fees (read: 5 ETFs to Bet on Post Fed Minutes).
The underlying S&P Health Care Services Select Industry Index holds 49 stocks in its portfolio. Health Care Services comprises 37% of the fund, followed by Health Care Facilities (26.6%) and Managed Health Care (22.7%). The fund has 28% exposure to large-cap stocks while small-cap stocks hold 50% share. Mid-cap stocks comprise the balance, It charges 35 bps in fees.
The fund puts 78% focus on Healthcare Equipments while Health Care Supplies takes the rest of it. Small-cap stocks occupy the majority share, while around 21% is held by large-cap stocks.
Stock Picks
Almost Family Inc.
This Zacks Rank #2 (Buy) company is a regionally focused provider of home health services.
It is a provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics and holds a Zacks Rank #2.
Market Cap: $ 448.04 million
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's Why Small-Cap HealthCare ETFs & Stocks Are Good Picks
Healthcare stocks are seen as relatively defensive and can provide safety to one’s portfolio during market downturns, which has been the case this year now. Ebbing fears related to price gouging, flurry of positive clinical trials, increasing health care spending, decent valuation have also been benefiting the sector.
Two particular factors are likely to act as wind beneath the wings of the healthcare sector, pushing up small-cap healthcare stocks and the related funds.
Tax Reform
Per an article published on Reuters, domestically geared healthcare companies that focus on services are likely to benefit from the lower tax rate. These companies have limited international exposure and considerable capital expenditures, as per the source.
Mizuho Securities indicated that “tax reform should be a significant positive cash flow event, especially for healthcare services companies that tend to have limited international exposure and significant capital expenditures.”
Merger and Acquisition
The U.S. healthcare supply chain is consolidating fast, with deals across the industry ranging from insurers, pharmacies to drug distributors. According to an article published on Bloomberg, smaller insurers like WellCare Health Plans Inc. , Centene Corp. (CNC - Free Report) , Molina Healthcare Inc. (MOH - Free Report) and Obamacare-focused startup Oscar Insurance Corp. appear to be lucrative acquisition targets. These companies may merge among themselves or can be lapped up by larger insurers eyeing scale advantage in a specific business area (read: Cigna to Buy Express Scripts: Healthcare ETFs in Focus).
The range of M&A activity is spreading beyond the healthcare sector. Leerink Partners analyst Ana Gupte noted retail giant, Walmart Inc. (WMT - Free Report) “has a co-branded Medicare drug plan with Humana that steers patients to Walmart stores -- which could make the retailer a prospective buyer of Humana.”
Like many analysts, we also believe that, if, as an investor, one wants to make a lot from a buyout premium, targeting small-cap stocks would be the best choice.
Against this backdrop, we highlight a few small-cap oriented stocks and ETFs for investors.
ETF Picks
PowerShares S&P SmallCap Health Care Portfolio (PSCH - Free Report)
The fund targets the S&P SmallCap 600 Capped Health Care Index. The 77-stock fund has a keen focus on Healthcare Equipment, Pharmaceuticals Suppliers and Providers & Services, which account for about 75% of the portfolio. The fund charges 29 bps in fees (read: 5 ETFs to Bet on Post Fed Minutes).
SPDR S&P Health Care Services ETF (XHS - Free Report)
The underlying S&P Health Care Services Select Industry Index holds 49 stocks in its portfolio. Health Care Services comprises 37% of the fund, followed by Health Care Facilities (26.6%) and Managed Health Care (22.7%). The fund has 28% exposure to large-cap stocks while small-cap stocks hold 50% share. Mid-cap stocks comprise the balance, It charges 35 bps in fees.
SPDR S&P Health Care Equipment ETF (XHE - Free Report)
The fund puts 78% focus on Healthcare Equipments while Health Care Supplies takes the rest of it. Small-cap stocks occupy the majority share, while around 21% is held by large-cap stocks.
Stock Picks
Almost Family Inc.
This Zacks Rank #2 (Buy) company is a regionally focused provider of home health services.
Market Cap: $817.9 million
Accuray Incorporated (ARAY - Free Report)
This Zacks Rank #2 stock is a global leader in the field of radiosurgery and a non-surgical treatment option for those diagnosed with cancer.
Market Cap: $494.7 million
Surmodics, Inc. (SRDX - Free Report)
It is a provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics and holds a Zacks Rank #2.
Market Cap: $ 448.04 million
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>